Global Biomarker-based Immunoassays Market Size & Outlook
Global biomarker-based immunoassays market, 2021-2033 (US$M)
Related Markets
Global biomarker-based immunoassays market highlights
- The global biomarker-based immunoassays market generated a revenue of USD 5,152.1 million in 2024 and is expected to reach USD 9,688.3 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 7.4% by 2033.
- In terms of segment, blood accounted for a revenue of USD 3,300.8 million in 2024.
- Saliva is the most lucrative sample segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 5,152.1 million |
| Market revenue in 2033 | USD 9,688.3 million |
| Growth rate | 7.4% (CAGR from 2025 to 2033) |
| Largest segment | Blood |
| Fastest growing segment | Saliva |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Blood, Tissue, Urine, Saliva |
Other key industry trends
- In terms of revenue, the North America accounted for 49.0% of the global biomarker-based immunoassays market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 293.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomarker-Based Immunoassays Market Scope
Biomarker-Based Immunoassays Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Global biomarker-based immunoassays market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarker-based immunoassays market will help companies and investors design strategic landscapes.
Blood was the largest segment with a revenue share of 64.07% in 2024. Horizon Databook has segmented the Global biomarker-based immunoassays market based on blood, tissue, urine, saliva covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Biomarker-Based Immunoassays Sample Outlook (Revenue, USD Million, 2021-2033)
- Blood
- Tissue
- Urine
- Saliva
- Global Biomarker-Based Immunoassays Product Outlook (Revenue, USD Million, 2021-2033)
- Reagents & Kits
- Consumables
- Instruments/Analyzers
- Services
- Global Biomarker-Based Immunoassays Biomarker Type Outlook (Revenue, USD Million, 2021-2033)
- Safety & Toxicity Biomarkers
- Efficacy & Pharmacodynamic Biomarkers
- Predictive & Prognostic Biomarkers
- Surrogate/Exploratory Biomarkers
- Global Biomarker-Based Immunoassays Drug Outlook (Revenue, USD Million, 2021-2033)
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Others Drug
- Global Biomarker-Based Immunoassays End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals & Clinics
- Diagnostic Laboratories
- Research & Academic Institutes
- Other End Use
Reasons to subscribe to Global biomarker-based immunoassays market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biomarker-based immunoassays market databook
-
Our clientele includes a mix of biomarker-based immunoassays market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biomarker-based immunoassays market , including forecasts for subscribers. This global databook contains high-level insights into Global biomarker-based immunoassays market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global biomarker-based immunoassays market size, by regions, 2021-2033 (US$M)
Top 10 countries: Biomarker-based immunoassays market size, 2024 (US$M)
Global biomarker-based immunoassays market share, by sample, 2024 & 2033 (%, US$M)
Biomarker-based immunoassays market: Opportunity assessment by country
Global biomarker-based immunoassays market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
